PTH and osteosarcoma: Although teriparatide does not increase the risk of osteosarcoma in adults (179) it is not recommended for osteoporosis in adult cancer patients (180, 181) due to lack of evidence and concerns that increased remodeling and parathyroid hormone signaling may create a “fertile soil” for the development of bone metastases.